Categories : Critical Care & Emergency
Product Packaging : 2 ml
Product Composition : 2 ml
Send MessageBupivacaine Hydrochloride in Dextrose Injection is a long-acting local anesthetic solution specifically designed for spinal anesthesia. The addition of dextrose enhances the solution’s density, allowing precise control over the spread of anesthesia, making it ideal for orthopedic, obstetric, urological, and lower abdominal surgeries.
As a leading Bupivacaine Hydrochloride in Dextrose Injection manufacturer and exporter in India, Genliva Wellness LLP delivers products compliant with international pharmaceutical standards, making it suitable for global hospital supply chains and pharma distributors. Its ready-to-use injectable form ensures accurate dosing, predictable sensory and motor blockade, and improved perioperative anesthesia workflow, minimizing the risk of complications.
The formulation offers rapid onset, prolonged duration, and hemodynamic stability, ensuring controlled spinal anesthesia for both elective and emergency surgeries. With Genliva Wellness LLP’s expertise as a contract manufacturer and global pharmaceutical exporter, this injection is a trusted B2B solution for hospitals, clinics, and international buyers seeking high-quality, export-ready anesthetic products.
Bupivacaine hydrochloride in dextrose injection is a hyperbaric spinal anesthetic formulation developed for regional anesthesia procedures. The addition of dextrose helps control the distribution of the anesthetic within the spinal canal for precise and prolonged nerve blockade.
This medication is used in spinal anesthesia techniques for procedures requiring temporary nerve blockade and pain control.
The formulation enables controlled spinal anesthesia with prolonged effect and dependable clinical performance during procedures.
